Healthcare Global Enterprises Ltd Share Price
(HCG)
Check the latest share price of Healthcare Global Enterprises Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 07 May 2025
NSE
Healthcare Global Enterprises Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹548.1Day's Price Range₹566.1552 Week's Low
52 Week's High
₹330.6552-Week Price Range₹601.95
| Returns % | |
| 1 Month Return | + 8.55 % |
| 3 Month Return | + 7.48 % |
| 1 Year Return | + 54.79 % |
| 3 Year Return | + 103.89 % |
| 5 Year Return | + 490.83 % |
| Market Stats | |
| Previous Close | ₹563.65 |
| Open | ₹563.65 |
| Volume | 2.43L |
| Upper Circuit | ₹676.35 |
| Lower Circuit | ₹450.95 |
Healthcare Global Enterprises Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹7,858.15 Cr
Return on Equity (ROE)
3.22
PE Ratio (TTM)
134.52
Return on capital employed (ROCE)
6.23
Industry PE ratio
101.9
Beta (LTM)
0.6
P/B Ratio
3.96
Dividend Yield
0PEG Ratio
81.04
Quarterly Earnings Growth YOY
125.95
EPS (TTM)
2.97
Sector
Healthcare
Book Value
59.28
Technical Analysis
Bullish
View Technical Analysis
How to invest in Healthcare Global Enterprises Ltd
Investing in Healthcare Global Enterprises Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Healthcare Global Enterprises Ltd or HCG on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Healthcare Global Enterprises Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Healthcare Global Enterprises Ltd with just a few clicks!
Healthcare Global Enterprises Ltd Valuation
Track how the P/E of Healthcare Global Enterprises Ltd has moved over time to understand valuation trends.
Healthcare Global Enterprises Ltd in the last 5 years
Lowest (-514.24x)
November 27, 2018
Industry (101.90x)
May 6, 2025
Today (134.52x)
May 6, 2025
Highest (201.31x)
July 2, 2018
Today’s Price to Earnings Ratio: 134.52x
Analysts Recommendation on Healthcare Global Enterprises Ltd
Get updated buy, sell, and hold recommendations by analysts on Healthcare Global Enterprises Ltd.
based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
85.71% of analysts recommend a 'BUY' rating for Healthcare Global Enterprises Ltd. Average target price of ₹537.43
Source: S&P Global Market Intelligence
Analysts Forecast on Healthcare Global Enterprises Ltd
Get share price movements and forecasts by analysts on Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises Ltd price forecast by 7 analysts
Downside of-4.65%
High
₹621
Target
₹537.43
Low
₹342
Healthcare Global Enterprises Ltd target price ₹537.43, a slight downside of -4.65% compared to current price of ₹552.55. According to 7 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Healthcare Global Enterprises Ltd revenue growth forecast
Expected growth rate Q1, FY2027:54.19%
Forecast
Actual
Including amortisation and stock based compensations
Healthcare Global Enterprises Ltd EPS growth forecast
EPS estimate Q1, FY2027:253.18%
Forecast
Actual
Source: S&P Global Market Intelligence
Healthcare Global Enterprises Ltd Financials
Get the annual and quarterly financial summary of Healthcare Global Enterprises Ltd, including revenue, profit, loss and more.
Healthcare Global Enterprises Ltd Index Inclusions
Healthcare Global Enterprises Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Healthcare Global Enterprises Ltd.
Healthcare Global Enterprises Ltd Earnings Results
Healthcare Global Enterprises Ltd’s net profit jumped 22.46% since last year same period to ₹6.98Cr in the Q3 2024-2025. On a quarterly growth basis, Healthcare Global Enterprises Ltd has generated -61.2% fall in its net profits since last 3-months.
Read More about Earnings Results
Healthcare Global Enterprises Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Healthcare Global Enterprises Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 71.22% | 0.00 | |
| Foreign Institutions | 2.45% | 0.00 | |
| Mutual Funds | 9.19% | 0.00 | |
| Retail Investors | 13.86% | 0.00 | |
| Others | 3.29% | 0.00 |
Healthcare Global Enterprises Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Healthcare Global Enterprises Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 7,858.15 | 98.17% | 0.70 | 41 | 1,907 | |
| BUY | 28,181.72 | 240.85% | 0.55 | 258 | 1,375 | |
| BUY | 8,635.74 | 7.44% | 0.58 | 128 | 1,207 | |
| NA | 23.90 | 98.57% | 0.62 | 3 | 22 | |
| NA | 235.17 | -2.53% | 0.59 | 2 | 22 |
Healthcare Global Enterprises Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Healthcare Global Enterprises Ltd.
HCG Expands Largest Private Oncology Facility in Gujarat - 21 Apr, 2025
HealthCare Global Enterprises Ltd (HCG) has inaugurated the expanded HCG Aastha Cancer Centre in Ahmedabad, now the largest private oncology facility in Gujarat, featuring a 217-bed capacity and advanced cancer care technologies. The expansion aims to enhance access to high-quality cancer treatment for patients in the region.KKR to Become Largest Shareholder in HCG - 16 Apr, 2025
On February 23, 2025, KKR announced a deal to acquire up to 54% equity in Healthcare Global Enterprises Ltd (HCG) from CVC at ₹445 per share, with plans to purchase additional shares from public shareholders. This transaction will position KKR as the largest shareholder, controlling between 54-77% of HCG's operations.
Insights on Healthcare Global Enterprises Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 13.06% to 13.86% in Mar 2025 quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, HCG has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
- POSITIVE IMPACT
Price Rise
In the last 6 months, HCG stock has moved up by 19.7%
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 218.0% return, outperforming this stock by 114.1%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 2.77% to 2.45% in Mar 2025 quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 71.23% to 71.22% in Mar 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 564.67 Cr → 564.11 Cr (in ₹), with an average decrease of 0.1% per quarter
- NEGATIVE IMPACT
MF Holding Down
Mutual Funds have decreased holdings from 10.04% to 9.19% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 17.99 Cr → 6.98 Cr (in ₹), with an average decrease of 61.2% per quarter
About Healthcare Global Enterprises Ltd
Established in 1998, HCG expanded its operations in 2016 with a successful Initial Public Offering (IPO) and launched advanced cancer centres in Baroda and Visakhapatnam. Later, in 2017, it acquired a majority stake in Cancer Care Kenya, and launched its first cancer centre in Kanpur with 90 dedicated beds. It is also setting up hospitals with high end linear accelerators in Kolkata and Nashik. HCG has been dedicated to delivering quality medical care across diagnosis and treatment, and its latest technologies like Robotic Surgery and Tomotherapy Treatment System are paving the way for a better tomorrow.
Revenue: ₹557.55Cr as on December 2024 (Q4 24)
Net Profit: ₹7.75Cr as on December 2024 (Q4 24)
Listing date: 30 Mar, 2016
Chairperson Name: BASAVALINGA AJAIKUMAR SADASHIVAIAH
| Organisation | Healthcare Global Enterprises Ltd |
| Headquarters | Bengaluru |
| Industry | Healthcare |
| CEO | BASAVALINGA AJAIKUMAR SADASHIVAIAH |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Healthcare Global Enterprises Ltd
Check out the Mutual Funds with significant holdings in Healthcare Global Enterprises Ltd.
FAQs
What is Healthcare Global Enterprises Ltd price today?
Healthcare Global Enterprises Ltd share price today stands at ₹552.55, Open: ₹563.65, Previous Close: ₹563.65, High: ₹566.15, Low: ₹548.1, 52 Week High: ₹601.95, 52 Week Low: ₹330.65.
How to Buy Healthcare Global Enterprises Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Healthcare Global Enterprises Ltd shares
What are today's traded volumes of Healthcare Global Enterprises Ltd?
Today's traded volume of Healthcare Global Enterprises Ltd(HCG) is 2.43L.
What is today's market capitalisation of Healthcare Global Enterprises Ltd?
Today's market capitalisation of Healthcare Global Enterprises Ltd(HCG) is ₹7,858.15 Cr.
What is the 52 Week High and Low Range of Healthcare Global Enterprises Ltd?
How much percentage Healthcare Global Enterprises Ltd is down from its 52 Week High?
Healthcare Global Enterprises Ltd (HCG) share price is ₹552.55. It is down -8.21% from its 52 Week High price of ₹601.95
How much percentage Healthcare Global Enterprises Ltd is up from its 52 Week low?
Healthcare Global Enterprises Ltd (HCG) share price is ₹552.55. It is up 67.11% from its 52 Week Low price of ₹330.65